Breaking News
Get 40% Off 0
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance Find Stocks Now
Close

Thermo Fisher Scientific Inc (TMO-RM)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
Thermo Fisher Scientific historical data, for real-time data please try another search
38,811.00 0.00    0.00%
24/02 - Real-time Data. Currency in RUB ( Disclaimer )
Type:  Equity
Market:  Russia
ISIN:  US8835561023 
  • Volume: 0
  • Bid/Ask: 0.00 / 0.00
  • Day's Range: 38,811.00 - 43,473.00
Thermo Fisher Scientific 38,811.00 0.00 0.00%

NYSE:TMO-RM Financials

 
A brief overview of the NYSE:TMO financials. This summary provides an overview of the most significant critical numbers from each of its financial reports, including the income statement, balance sheet, and cash flow statement. Additionally, it features several financial ratios that provide insight into the company's financial health. Users can select to view data from four periods of either annual or quarterly information, allowing them to track financial performance of Thermo Fisher over time.

Thermo Fisher Scientific Inc. reported earnings results for the third quarter and nine months ended September 30, 2023. For the third quarter, the company reported sales was USD 10,574 million compared to USD 10,677 million a year ago. Net income was USD 1,715 million compared to USD 1,495 million a year ago. Basic earnings per share from continuing operations was USD 4.44 compared to USD 3.82 a year ago. Diluted earnings per share from continuing operations was USD 4.42 compared to USD 3.79 a year ago.For the nine months, sales was USD 31,971 million compared to USD 33,465 million a year ago. Net income was USD 4,365 million compared to USD 5,374 million a year ago. Basic earnings per share from continuing operations was USD 11.31 compared to USD 13.72 a year ago. Diluted earnings per share from continuing operations was USD 11.25 compared to USD 13.62 a year ago.

AnnualQuarterly  
InvestingPro Advanced Financial Summary
TTM = Trailing Twelve Months
MRQ = Most Recent Quarter

TMO-RM Income Statement

Gross margin TTM 39.93%
Operating margin TTM -
Net Profit margin TTM -
Return on Investment TTM -
 Total Revenue  Net Income
Period Ending: Dec 31, 2023 Sep 30, 2023 Jul 01, 2023 Apr 01, 2023
Total Revenue 10886 10574 10687 10710
Gross Profit 4396 4321 4258 4171
Operating Income 2031 1949 1764 1714
Net Income 1630 1715 1361 1289

TMO-RM Balance Sheet

Quick Ratio MRQ -
Current Ratio MRQ 1.75
LT Debt to Equity MRQ -
Total Debt to Equity MRQ -
 Total Assets  Total Liabilities
Period Ending: Dec 31, 2023 Sep 30, 2023 Jul 01, 2023 Apr 01, 2023
Total Assets 98726 97057 94105 94658
Total Liabilities 51884 51593 50190 52225
Total Equity 46842 45464 43915 42433

TMO-RM Cash Flow Statement

Cash Flow/Share TTM -
Revenue/Share TTM -
Operating Cash Flow  26.57%
 Cash  Net Change in Cash
Period Ending: Dec 31, 2023 Sep 30, 2023 Jul 01, 2023 Apr 01, 2023
Period Length: 0 Months 0 Months 0 Months 0 Months
Cash From Operating Activities 3723 2414 1540 729
Cash From Investing Activities -376 -1181 -443 -3142
Cash From Financing Activities -1428 1855 -1456 -2593
Net Change in Cash 1929 3015 -347 -5037
* In Millions of USD (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

TMO Comments

Write your thoughts about Thermo Fisher Scientific Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Franjo Tahi
Franjo Tahi Oct 25, 2023 11:29AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
why not 200% up ?
Ashraf Mahmoud
Ashraf Mahmoud Jul 28, 2022 8:01AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
30% up
Ashraf Mahmoud
Ashraf Mahmoud May 20, 2022 3:54PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
20% up next week
David Lousada
David Lousada Dec 06, 2021 11:41AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
why falling ao hard today?
Yung Money
Yung Money Oct 27, 2021 2:40AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
does this thermo site pay 💵💴
nn st
nn st Jun 02, 2021 11:15AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
good news for TMO,, moderna :announces agreement with TMO for finish manufacturing of moderna covid 19 vaccine
Jun 02, 2021 11:15AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
A Valid reason for going down
Makoto Kondo
Makoto Kondo Jun 01, 2021 10:07AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
What happened??
EEKKNNDD WW
EEKKNNDD WW Jun 01, 2021 10:07AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Musn here we go?129?
Alvar Esteban
Alvar Esteban Jan 12, 2021 4:17AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
You North Americans do not use this web/app for forums communications... where is people? Where takes place the stock market discussion?
Minna Andreasen
Minna Andreasen Jan 12, 2021 4:17AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Twitter etc
Jan 12, 2021 4:17AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Let's discuss bro
Duane Goodson
Duane Goodson Jan 05, 2021 2:09PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
RDGL approval or denial by Jan 16 by the FDA for breakthrough designation for their tumor fighting drug
Info Buffet
Info Buffet Dec 30, 2020 2:26PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Needham analyst Stephen Unger reiterated a Buy rating on Thermo Fisher on Wednesday, setting a price target of $539
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email